Turtle Cameron — Chief Executive Officer
Insider trading activity for Turtle Cameron sourced from SEC EDGAR Form 4 filings.
Overview
- Title: Chief Executive Officer
- Company: Spyre Therapeutics, Inc.
- Total insider trades: 22
- Total buy volume: $0
- Total sell volume: $6.9M
- Last trade: Oct 2, 2026
Recent Trades
| Date | Insider | Ticker / Company | Type | Shares | Value |
|---|---|---|---|---|---|
| Oct 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 100 | $9K |
| Oct 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 4,990 | $466K |
| Oct 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 3,989 | $368K |
| Oct 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 2,638 | $241K |
| Oct 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 2,683 | $242K |
| Oct 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 600 | $53K |
| Sep 1, 2026 | Turtle Cameron | SSYRE SSYRE | SELL | 15,000 | $1.3M |
| Jul 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 590 | $52K |
| Jul 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 4,234 | $373K |
| Jul 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 10,176 | $890K |
| Jun 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 3,294 | $235K |
| Jun 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 8,149 | $575K |
| Jun 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 3,557 | $247K |
| May 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 300 | $22K |
| May 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 1,700 | $126K |
| May 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 3,100 | $227K |
| May 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 1,000 | $72K |
| May 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 3,600 | $255K |
| May 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 5,300 | $369K |
| Apr 1, 2026 | Turtle Cameron | SYRE Spyre Therapeutics, Inc. | SELL | 2,656 | $133K |